Creating 'Partnership in iSupport program' to optimise family carers' impact on dementia care: a randomised controlled trial protocol.

Carers Community aged care Cost-effectiveness Dementia Health services research Knowledge translation Online education Quality of life Randomised controlled trial Virtual social support

Journal

BMC health services research
ISSN: 1472-6963
Titre abrégé: BMC Health Serv Res
Pays: England
ID NLM: 101088677

Informations de publication

Date de publication:
10 Jun 2022
Historique:
received: 12 05 2022
accepted: 01 06 2022
entrez: 10 6 2022
pubmed: 11 6 2022
medline: 15 6 2022
Statut: epublish

Résumé

The majority of people with dementia are cared for by their family members. However, family carers are often unprepared for their caring roles, receiving less education and support compared with professional carers. The consequences are their reduced mental and physical health and wellbeing, and that of care recipients. This study protocol introduces the 'Partnership in iSupport program' that includes five interventional components: managing transitions, managing dementia progression, psychoeducation, carer support group and feedback on services. This health services research is built on family carer and dementia care service provider partnerships. The aims of the study are to evaluate the effectiveness, cost-effectiveness and family carers' experiences in the program. A multicentre randomised controlled trial will be conducted with family carers of people living with dementia from two tertiary hospitals and two community aged care providers across three Australian states. The estimated sample size is 185 family carers. They will be randomly assigned to either the intervention group or the usual care group. Outcomes are measurable improvements in quality of life for carers and people with dementia, caregiving self-efficacy, social support, dementia related symptoms, and health service use for carers and their care recipients. Data will be collected at three time points: baseline, 6 months and 12 months post-initiation of the intervention. This is the first large randomised controlled trial of a complex intervention on health and social care services with carers of people living with dementia in real-world practice across hospital and community aged care settings in three Australian states to ascertain the effectiveness, cost-effectiveness and carers' experiences of the innovative program. We expect that this study will address gaps in supporting dementia carers in health and social care systems while generating new knowledge of the mechanisms of change in the systems. Findings will strengthen proactive health management for both people living with dementia and their carers by embedding, scaling up and sustaining the 'Partnership in iSupport program' in the health and social care systems. The Australian New Zealand Clinical Trials Registry (ANZCTR). ACTRN12622000199718 . Registered February 4

Sections du résumé

BACKGROUND BACKGROUND
The majority of people with dementia are cared for by their family members. However, family carers are often unprepared for their caring roles, receiving less education and support compared with professional carers. The consequences are their reduced mental and physical health and wellbeing, and that of care recipients. This study protocol introduces the 'Partnership in iSupport program' that includes five interventional components: managing transitions, managing dementia progression, psychoeducation, carer support group and feedback on services. This health services research is built on family carer and dementia care service provider partnerships. The aims of the study are to evaluate the effectiveness, cost-effectiveness and family carers' experiences in the program.
METHODS METHODS
A multicentre randomised controlled trial will be conducted with family carers of people living with dementia from two tertiary hospitals and two community aged care providers across three Australian states. The estimated sample size is 185 family carers. They will be randomly assigned to either the intervention group or the usual care group. Outcomes are measurable improvements in quality of life for carers and people with dementia, caregiving self-efficacy, social support, dementia related symptoms, and health service use for carers and their care recipients. Data will be collected at three time points: baseline, 6 months and 12 months post-initiation of the intervention.
DISCUSSION CONCLUSIONS
This is the first large randomised controlled trial of a complex intervention on health and social care services with carers of people living with dementia in real-world practice across hospital and community aged care settings in three Australian states to ascertain the effectiveness, cost-effectiveness and carers' experiences of the innovative program. We expect that this study will address gaps in supporting dementia carers in health and social care systems while generating new knowledge of the mechanisms of change in the systems. Findings will strengthen proactive health management for both people living with dementia and their carers by embedding, scaling up and sustaining the 'Partnership in iSupport program' in the health and social care systems.
TRIAL REGISTRATION BACKGROUND
The Australian New Zealand Clinical Trials Registry (ANZCTR). ACTRN12622000199718 . Registered February 4

Identifiants

pubmed: 35689281
doi: 10.1186/s12913-022-08148-2
pii: 10.1186/s12913-022-08148-2
pmc: PMC9185883
doi:

Types de publication

Clinical Trial Protocol Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

762

Subventions

Organisme : National Health and Medical Research Council
ID : MRF2008321
Organisme : Dementia Collaborative Research Centres, Australia
ID : World-Class Research Project Grants

Informations de copyright

© 2022. The Author(s).

Références

Int J Geriatr Psychiatry. 2018 Feb;33(2):e166-e176
pubmed: 28796303
Psychol Aging. 2020 Feb;35(1):55-77
pubmed: 31985249
J Gerontol B Psychol Sci Soc Sci. 2002 Jan;57(1):P74-86
pubmed: 11773226
Gerontologist. 2019 Sep 17;59(5):e597-e610
pubmed: 29878117
Pharmacoeconomics. 2020 Aug;38(8):871-881
pubmed: 32314315
BMJ. 2014 Mar 07;348:g1687
pubmed: 24609605
Int J Geriatr Psychiatry. 2019 Jan;34(1):8-21
pubmed: 30260050
Lancet. 2020 Aug 8;396(10248):413-446
pubmed: 32738937
Aging Ment Health. 2014;18(8):954-69
pubmed: 24943873
BMJ. 2021 Sep 30;374:n2061
pubmed: 34593508
Int J Geriatr Psychiatry. 2016 Nov;31(11):1151-1171
pubmed: 27045271
J Am Med Dir Assoc. 2021 Jul;22(7):1371-1376
pubmed: 34081893
Med Care. 1996 Mar;34(3):220-33
pubmed: 8628042
Health Soc Care Community. 2020 Nov;28(6):1942-1960
pubmed: 32542963
Am J Geriatr Psychiatry. 2015 Mar;23(3):293-303
pubmed: 24935785
Psychosom Med. 2002 May-Jun;64(3):510-9
pubmed: 12021425
PLoS One. 2019 May 10;14(5):e0216112
pubmed: 31075120
Dementia (London). 2021 Jul;20(5):1536-1552
pubmed: 32864991
BMC Geriatr. 2020 Feb 11;20(1):49
pubmed: 32046657
J Adv Nurs. 2020 Mar;76(3):787-802
pubmed: 31808211
SAGE Open Med. 2018 Aug 16;6:2050312118792812
pubmed: 35154748
Implement Sci. 2010 Dec 30;5:99
pubmed: 21192817
Psychol Aging. 1992 Dec;7(4):622-31
pubmed: 1466831
BMC Geriatr. 2017 Dec 12;17(1):286
pubmed: 29233097
J Am Geriatr Soc. 2019 Mar;67(3):609-617
pubmed: 30536383
J Am Geriatr Soc. 2020 Oct;68(10):2240-2248
pubmed: 32700399
J Am Geriatr Soc. 2014 Feb;62(2):276-84
pubmed: 24502827
Health Res Policy Syst. 2022 Mar 24;20(1):34
pubmed: 35331260
Value Health. 2007 Sep-Oct;10(5):336-47
pubmed: 17888098
Aging Ment Health. 2021 Jul;25(7):1165-1180
pubmed: 32363901
BMJ Open. 2015 Apr 13;5(4):e006808
pubmed: 25869686
J Am Geriatr Soc. 1992 Sep;40(9):922-35
pubmed: 1512391
Ann Intern Med. 2013 Feb 5;158(3):200-7
pubmed: 23295957
BMC Health Serv Res. 2020 Jun 23;20(1):573
pubmed: 32576197
Maturitas. 2018 Jun;112:39-45
pubmed: 29704916
Health Soc Care Community. 2020 Sep;28(5):1408-1429
pubmed: 32223022
BMC Health Serv Res. 2016 Jul 19;16:285
pubmed: 27435089
Implement Sci. 2016 Mar 10;11:33
pubmed: 27013464
Alzheimers Dement. 2017 May;13(5):572-581
pubmed: 28167069
J Am Geriatr Soc. 2020 Jul;68 Suppl 2:S14-S20
pubmed: 32589282
Am J Geriatr Psychiatry. 2019 Feb;27(2):149-161
pubmed: 30477913
Gerontologist. 2018 Jan 18;58(suppl_1):S129-S140
pubmed: 29361067
Br J Clin Psychol. 2022 Mar;61(1):112-131
pubmed: 34156110
J Clin Epidemiol. 2010 Aug;63(8):e1-37
pubmed: 20346624

Auteurs

Lily Xiao (L)

College of Nursing and Health Sciences, Flinders University, Bedford Park, South Australia, 5042, Australia. lily.xiao@flinders.edu.au.

Ying Yu (Y)

College of Nursing and Health Sciences, Flinders University, Bedford Park, South Australia, 5042, Australia.

Julie Ratcliffe (J)

College of Nursing and Health Sciences, Flinders University, Bedford Park, South Australia, 5042, Australia.

Rachel Milte (R)

College of Nursing and Health Sciences, Flinders University, Bedford Park, South Australia, 5042, Australia.

Claudia Meyer (C)

College of Nursing and Health Sciences, Flinders University, Bedford Park, South Australia, 5042, Australia.
Bolton Clarke Research Institute, Melbourne, VIC, Australia.
Adjunct Research Fellow; Rehabilitation, Ageing and Independent Living Research Centre, Monash University, Melbourne, Australia.
Honorary Associate, Centre for Health Communication and Participation, La Trobe University, Melbourne, Australia.

Michael Chapman (M)

Canberra Health Services, ACT, Canberra, Australia.

Langduo Chen (L)

College of Nursing and Health Sciences, Flinders University, Bedford Park, South Australia, 5042, Australia.
Southern Adelaide Local Health Network, Adelaide, South Australia, Australia.

Shahid Ullah (S)

College of Medicine and Public Health, Flinders University, Bedford Park, South Australia, Australia.

Alison Kitson (A)

College of Nursing and Health Sciences, Flinders University, Bedford Park, South Australia, 5042, Australia.

Andre Queiroz De Andrade (AQ)

Quality Use of Medicines and Pharmacy Research Centre, Clinical and Medical Sciences, University of South Australia, Adelaide, Australia.

Elizabeth Beattie (E)

Queensland Dementia Training Study Centre, School of Nursing, Queensland University of Technology, Brisbane, QLD, Australia.

Henry Brodaty (H)

Centre for Healthy Brain Ageing (CHeBA), School of Psychiatry, University of New South Wales, Sydney, NSW, Australia.

Sue McKechnie (S)

Community Services, Resthaven Incorporated, Wayville, South Australia, Australia.

Lee-Fay Low (LF)

Faculty of Health Sciences, University of Sydney, Sydney, Australia.

Tuan Anh Nguyen (TA)

Social Gerontology Division, National Ageing Research Institute, Melbourne, Australia.

Craig Whitehead (C)

Southern Adelaide Local Health Network, Adelaide, South Australia, Australia.

Bianca Brijnath (B)

Social Gerontology Division, National Ageing Research Institute, Melbourne, Australia.
School of Allied Health, Curtin University, Bentley, West Australia, Australia.

Ronald Sinclair (R)

Faculty of Sciences, University of Adelaide, Adelaide, Australia.

Diana Voss (D)

Southern Adelaide Local Health Network, Adelaide, South Australia, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH